Idexx Laboratories (IDXX) Net Cash Flow (2009 - 2026)

Idexx Laboratories' Net Cash Flow history runs 18 years deep, the most recent figure standing at $21.3 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 117.44% year-over-year to $21.3 million; the TTM figure through Mar 2026 stood at $23.8 million (up 110.57% YoY), while the FY2025 annual figure was -$119.4 million, up 23.53% from the prior year.
• Net Cash Flow was $21.3 million for Q1 2026 at Idexx Laboratories, up from -$28.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $201.6 million in Q3 2023 to a low of -$122.0 million in Q1 2025.
• Historically, Net Cash Flow has averaged $3.6 million across 5 years, with a median of -$1.7 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow jumped 7091.35% in 2022, then plunged 3021.01% in 2024.
• A 5-year view of Net Cash Flow shows it stood at $7.5 million in 2022, then jumped by 1472.03% to $117.6 million in 2023, then plunged by 109.02% to -$10.6 million in 2024, then tumbled by 164.83% to -$28.1 million in 2025, then jumped by 175.78% to $21.3 million in 2026.
• The last three Net Cash Flow figures came in at $21.3 million (Q1 2026), -$28.1 million (Q4 2025), and $44.2 million (Q3 2025), per Business Quant data.